Home/Notes/Chemotherapy of Infections & Malignancy
Board Exam Notes

Chemotherapy of Infections & Malignancy Notes

Questions

1–2 long answer questions or 4–6 MCQs per paper

Difficulty

Medium-Hard

Importance

High yield for GPAT and B.Pharm University theory exams

Overview

Chemotherapy of infections and malignancy focuses on the selective toxicity of drugs against invading microorganisms and abnormal cell growth. Mastering this topic is essential for pharmaceutical exams as it bridges the gap between biochemical mechanisms and clinical therapeutic outcomes, which is a frequent source of long-form analytical questions.

Antibiotics: SAR and Mechanism

Antibiotics are classified based on their target sites and chemical scaffolds, which determine their spectrum and potency. Structure-Activity Relationship (SAR) studies emphasize the importance of specific functional groups, such as the beta-lactam ring in penicillins, for effective binding and inhibition.

  • Beta-lactam mechanism: Inhibition of transpeptidase enzymes
  • Penicillin SAR: 6-aminopenicillanic acid nucleus is essential
  • Tetracycline mechanism: Reversible binding to the 30S ribosomal subunit
  • Aminoglycosides: Misreading of mRNA codon leading to protein synthesis failure
  • Sulfonamides: Competitive inhibition of dihydropteroate synthase

Antimalarials

Antimalarial agents target the life cycle of the Plasmodium parasite, particularly within the human erythrocytic stage. Understanding the classification into quinoline derivatives and antifolates is critical for explaining their distinct mechanisms of action.

  • Chloroquine: Inhibition of heme polymerase causing toxic accumulation of heme
  • Primaquine: Used for the radical cure of P. vivax to eliminate liver hypnozoites
  • Artemisinin derivatives: Form free radicals via interaction with iron in the parasite
  • Pyrimethamine: Selective inhibition of dihydrofolate reductase
  • Quinine: Interferes with parasite DNA replication and membrane function

Anticancer Drugs

Anticancer chemotherapy involves the use of cytotoxic agents that interfere with the rapid cell division cycle of malignant cells. These drugs are categorized by their chemical nature and the specific phase of the cell cycle they interrupt.

  • Alkylating agents: Form covalent bonds with DNA, causing cross-linking (e.g., Cyclophosphamide)
  • Antimetabolites: Act as structural analogs of natural metabolites (e.g., 5-Fluorouracil)
  • Vinca alkaloids: Bind to tubulin to prevent spindle formation in the M-phase
  • Anthracyclines: Intercalate between DNA base pairs and inhibit topoisomerase II
  • Cisplatin: Causes intrastrand DNA cross-linking leading to apoptosis

Exam Tip

Focus on the specific molecular target (enzyme or receptor) for each drug class rather than memorizing long lists of brand names.

Common Mistakes

  • Confusing the spectrum of action between bacteriostatic and bactericidal drugs.
  • Neglecting the significance of the 6-APA nucleus in penicillin SAR descriptions.
  • Misidentifying cell cycle-specific vs. cell cycle-non-specific anticancer agents.

More Revision Notes

Ready to test yourself?

Play topic-wise Chemotherapy of Infections & Malignancy questions in Aspirant Arcade — gamified MCQ practice.

Download Free